NEW YORK (GenomeWeb) – After securing $2 million in seed funding in January, molecular diagnostics startup IQuity Labs is nearing the launch of its first product, a blood-based test to diagnose multiple sclerosis (MS) at the onset of symptoms, with additional tests in gastroenterology and rheumatology expected to follow over the following 12 months.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.